Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Wahrmann

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Clinical Transplants|June 24, 2011
Bortezomib for the treatment of chronic antibody-mediated kidney allograft rejection: a case reportElisabeth Schwaiger, Heinz Regele, Markus Wahrmann, et al.
Transplantation|December 4, 2010
Significance of peritubular capillary, glomerular, and arteriolar C4d staining patterns in paraffin sections of early kidney transplant biopsiesZeljko Kikić, Heinz Regele, Veit Nordmeyer, et al.
Transplantation|April 7, 2007
Determinants of the complement-fixing ability of recipient presensitization against HLA antigensGregor Bartel, Markus Wahrmann, Markus Exner, et al.
Human Immunology|November 16, 2010
Prevalence and qualitative properties of circulating anti-human leukocyte antigen alloantibodies after pregnancy: no association with unexplained recurrent miscarriageGregor Bartel, Katharina Walch, Markus Wahrmann, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 22, 2009
Clinical relevance of preformed C4d-fixing and non-C4d-fixing HLA single antigen reactivity in renal allograft recipientsMarkus Wahrmann, Gregor Bartel, Markus Exner, et al.
Journal of the American Society of Nephrology : JASN|December 18, 2010
Genotypic diversity of complement component C4 does not predict kidney transplant outcomeMarkus Wahrmann, Bernd Döhler, Andrea Ruhenstroth, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 17, 2011
Anti-A/B antibody depletion by semiselective versus ABO blood group-specific immunoadsorptionMarkus Wahrmann, Martin Schiemann, Lena Marinova, et al.
Clinical Transplants|June 8, 2010
Proteasome inhibition for recipient desensitization? A report of two sensitized kidney transplant candidates subjected to bortezomib treatmentMarkus Wahrmann, Michael Haidinger, Johannes Drach, et al.
Frontiers in Immunology|May 23, 2015
Surface Plasmon Resonance Analysis Shows an IgG-Isotype-Specific Defect in ABO Blood Group Antibody Formation in Patients with Common Variable ImmunodeficiencyMichael B Fischer, Wendelin Wolfram, Christoph J Binder, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|April 29, 2025
COVID-19 mRNA-1273 vaccination induced mast cell activation with strongly elevated Th<sub>2</sub> cytokines in a systemic mastocytosis patientMatthias Weiss-Tessbach, Teresa Haider, Aoife Gowran, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Clinical Transplants|June 24, 2011
Bortezomib for the treatment of chronic antibody-mediated kidney allograft rejection: a case reportElisabeth Schwaiger, Heinz Regele, Markus Wahrmann, et al.
Transplantation|December 4, 2010
Significance of peritubular capillary, glomerular, and arteriolar C4d staining patterns in paraffin sections of early kidney transplant biopsiesZeljko Kikić, Heinz Regele, Veit Nordmeyer, et al.
Transplantation|April 7, 2007
Determinants of the complement-fixing ability of recipient presensitization against HLA antigensGregor Bartel, Markus Wahrmann, Markus Exner, et al.
Human Immunology|November 16, 2010
Prevalence and qualitative properties of circulating anti-human leukocyte antigen alloantibodies after pregnancy: no association with unexplained recurrent miscarriageGregor Bartel, Katharina Walch, Markus Wahrmann, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 22, 2009
Clinical relevance of preformed C4d-fixing and non-C4d-fixing HLA single antigen reactivity in renal allograft recipientsMarkus Wahrmann, Gregor Bartel, Markus Exner, et al.
Journal of the American Society of Nephrology : JASN|December 18, 2010
Genotypic diversity of complement component C4 does not predict kidney transplant outcomeMarkus Wahrmann, Bernd Döhler, Andrea Ruhenstroth, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 17, 2011
Anti-A/B antibody depletion by semiselective versus ABO blood group-specific immunoadsorptionMarkus Wahrmann, Martin Schiemann, Lena Marinova, et al.
Clinical Transplants|June 8, 2010
Proteasome inhibition for recipient desensitization? A report of two sensitized kidney transplant candidates subjected to bortezomib treatmentMarkus Wahrmann, Michael Haidinger, Johannes Drach, et al.
Frontiers in Immunology|May 23, 2015
Surface Plasmon Resonance Analysis Shows an IgG-Isotype-Specific Defect in ABO Blood Group Antibody Formation in Patients with Common Variable ImmunodeficiencyMichael B Fischer, Wendelin Wolfram, Christoph J Binder, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|April 29, 2025
COVID-19 mRNA-1273 vaccination induced mast cell activation with strongly elevated Th<sub>2</sub> cytokines in a systemic mastocytosis patientMatthias Weiss-Tessbach, Teresa Haider, Aoife Gowran, et al.
Pageof 7